EUVIMEDEUVIMED entdecken
Open Access

Cell Killing by Anti-HIV Immunoconjugates Demonstrates Overlap among Metabolic and Transcriptional Pathways of Death and Activation

Seth H Pincus, Tami Peters, Megan Stackhouse, Galen O'Shea-Stone, Frances M Cole, Brian Tripet, Valérie Copié

ACS Pharmacology & Translational Science · 13.11.2026 · 9 (11) · 3241-3254

DOI: 10.1021/acsptsci.6c00433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 26.10.2026. Verfasst von Seth H Pincus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Chemistry & Biochemistry, Montana State University, Bozeman MT USA 59717. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCRR NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In testing monoclonal antibody (mAb)-based therapies to eradicate the persistent reservoir of HIV infection, we compared the killing of HIV-infected cells by different forms of cytotoxic immunoconjugates (CICs) targeted by the same mAb. CICs consisted of the anti-HIV mAb 7B2 conjugated to either deglycosylated ricin A chain (dgA) or to the anthracycline derivative PNU-159682. At intervals up to 24 h post treatment intracellular metabolites were identified and quantified by 1H nuclear magnetic resonance spectroscopy; the transcriptome was analyzed by RNA-Seq. Six h post treatment, 7B2-dgA elicited both metabolic and transcriptional alterations, whereas 7B2-PNU treated cells did not differ from untreated cells. By 24 h, both 7B2-dgA and 7B2-PNU treated cells differed markedly from untreated. Among the earliest changes following both treatments were activation of gene pathways for apoptosis, intracellular signaling, and those associated with immune activation. Elevated intracellular levels of branched chain amino acids, typically observed with immune activation, were also observed. There were also changes unique to each treatment. The results demonstrate close relationships of the events associated with immune cell activation and those of cell death, and suggest where these processes may diverge. Differences between the two forms of CIC were also noted, the clinical significance of which remains to be investigated.

Schlagwörter

Stichwörter der Autor:innen

AntibodyCell deathHuman immunodeficiency virus (HIV)ImmunotherapyMetabolismTranscriptomics

Autor:innen und Institutionen

  • Dept of Chemistry & Biochemistry, Montana State University, Bozeman MT USA 59717.

Förderung

  • NIAID NIH HHS
  • NCRR NIH HHS
  • National Science Foundation
  • National Institutes of Health
  • M.J. Murdock Charitable Trust
  • Montana State University

Zitieren

APA

Pincus, S. H., Peters, T., Stackhouse, M., O'Shea-Stone, G., Cole, F. M., Tripet, B., & Copié, V. (2026). Cell Killing by Anti-HIV Immunoconjugates Demonstrates Overlap among Metabolic and Transcriptional Pathways of Death and Activation. ACS Pharmacology & Translational Science, 9(11), 3241-3254. https://doi.org/10.1021/acsptsci.6c00433

Vancouver

Pincus SH, Peters T, Stackhouse M, O'Shea-Stone G, Cole FM, Tripet B, et al. Cell Killing by Anti-HIV Immunoconjugates Demonstrates Overlap among Metabolic and Transcriptional Pathways of Death and Activation. ACS Pharmacology & Translational Science. 2026;9(11):3241-3254. doi:10.1021/acsptsci.6c00433

BibTeX
@article{Pincus2026,
  author = {Pincus, Seth H and Peters, Tami and Stackhouse, Megan and O'Shea-Stone, Galen and Cole, Frances M and Tripet, Brian and Copié, Valérie},
  title = {Cell Killing by Anti-HIV Immunoconjugates Demonstrates Overlap among Metabolic and Transcriptional Pathways of Death and Activation},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {3241--3254},
  doi = {10.1021/acsptsci.6c00433}
}
Kostenlos starten →